비알콜성 지방간질환의 한방치료에 대한 체계적 문헌고찰

키워드

참고문헌 (56)

1. The Korean Association for the Study of the Liver, "Non-Alcoholic Fatty Liver Disease Guidelines", pp.12~33 (2013), Doseochulpan jingihoeg
2. Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", J Gastroenterol Hepatol, 21(1), pp.138~143 (2006)
3. Bae JC, "Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects", Am J Gastroenterol, 105(11), pp.2389~2395 (2010)
4. Choi SY, "The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans", Am J Gastroenterol, 104(8), pp.1953~1960 (2009)
5. Kasper DL, "Harrison's Principles of Internal Medicine", pp.2931~2935 (2015), McGraw-Hill Education Korea, Ltd. and Medical Information Provider
6. Cheon GJ, "Role of pharmacologic treatment of NAFLD:Cons", The Korean journal of internal medicine, pp.251~256 (2018)
7. Brolin RE, "Unsuspected cirrhosis discovered during elective obesity operations", Archives of surgery, 133(1), pp.84~88 (1998)
8. Dallal RM, "Results of laparoscopic gastric bypass in patients with cirrhosis", Obesity Surgery, 14(1), pp.47~53 (2004)
9. Jeongughanuigwadaehag gangyenaegwahaggyosil, "Gangyenaegwahag", pp.321~328 (2013), Nado
10. Chen L, "Effects of resolving phlegm method on fibrinolytic status in non-alcoholic steatohepatitis patients of phlegm and blood-stasis syndrome", Chinese Journal of Integrated Traditional and Western Medicine, 26(12), pp.1090~1093 (2006)
11. Gu CL, "Effect of Tiaozhi Yanggan Decoction(调脂养肝汤)in treating patients with non-alcoholic fatty liver", Chinese Association of Traditional and Western Medicine, 13(4), pp.275~279 (2007)
12. Huang Z, "Non-alcoholic fatty liver disease of liver stagnation and spleen deficiency pattern treated with acupoint embedding therapy : a randomized controlled trial", Chinese acupuncture &moxibustion, 36(2), pp.119~142 (2016)
13. Ji G, "Effectiveness of Danning Tablet in Patients with non-alcoholic Fatty Liver of damp-heat Syndrome Type : A Multicenter Randomized Controlled Trial", Journal of Chinese Integrative Medicine, 6(2), pp.128~134 (2008)
14. Li L, "Treatment of non-alcoholic fatty liver disease by Qianggan Capsule(强肝胶囊)", Chinese Association of Traditional and Western Medicine, 16(1), pp.23~27 (2010)
15. Lou SY, "Effects of Yiqi Sanju Formula on non-alcoholic fatty liver disease : a randomized controlled trial", Journal of Chinese Integrative Medicine, 6(8), pp.793~798 (2008)
16. Meng SX, "Observation on therapeutic effect of acupuncture for treatment of patients with nonalcoholic steatohepatitis", Chinese acupuncture &moxibustion, 29(8), pp.616~624 (2009)
17. Panahi Y, "Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease : A Randomized Controlled Trial", Drug research, 37(4), pp.244~251 (2017)
18. Rahmani S, "Treatment of Non-alcoholic Fatty Liver Disease with Curcumin : A Randomized Placebo-controlled Trial", Phytotherapy Research, 30(9), pp.1540~1548 (2016)
19. Tang JM, "Efficacy of Zaozhu Yinchen Recipe for Treating Non-alcoholic Steatohepatitis and its Effect on Free Fatty Acid and TNF-alpha", Chinese Journal of Integrated Traditional and Western Medicine, 36(5), pp.544~552 (2016)
20. Wang YL, "Yiqi Huoxue Recipe combined with polyene phosphatidylcholine capsule in treating 50 patients with non-alcoholic fatty hepatitis", Chinese Journal of Integrated Traditional and Western Medicine, 27(2), pp.162~166 (2007)
21. Zhang SJ, "The effect of QuYuHuaTanTongLuo Decoction on the non-alcoholic steatohepatitis", Complement Ther Med, 16(4), pp.192~198 (2008)
22. 김동희, "불면장애에 대한 혈부축어탕의 체계적 문헌 고찰 및 메타분석 연구", 동의신경정신과학회지, 28(4), pp.319~332 (2017), 대한한방신경정신과학회
23. 구지향, "무릎 골관절염의 봉독 약침 치료에 대한 체계적 문헌 고찰", 한방재활의학과학회지, 27(3), pp.47~60 (2017), 한방재활의학과학회
24. 한인식, "본태성 고혈압에 대한 杞菊地黄丸의 효과에 관한 체계적 고찰 및 메타 분석", 동의생리병리학회지, 31(2), pp.118~125 (2017), 한의병리학회[DOI]
25. Kim SY, "NECA's guidance for undertaking systematic reviews and meta-analyses for intervention", National Evidence-based Healthcare Collaborating Agency, ~ (2011)
26. 현준, "비알코올성 지방간 질환에 대한 침치료의 효과 : 체계적 고찰", 대한한방내과학회지, 39(6), pp.1206~1224 (2018), 대한한방내과학회
27. 박연화, "비알콜성지방간의 유병율과 병리기전에 대한 문헌적 고찰", 대한한방내과학회지, 32(1), pp.26~32 (2011), 대한한방내과학회
28. 조주흠, "고지방식이 비만마우스 모델에서 파키스탄산 및 중국산 마황으로 조성된 降脂丸의 비알콜성 지방간질환 개선효과 비교", 대한한의학 방제학회지, 22(1), pp.113~122 (2014), 대한한의학방제학회
29. 안예지, "고지방식이 C57BL", 6N 모델에서 降脂丸의 농도별 비알콜성 지방간질환 개선효과, 2014, pp.29(2), 47~54[DOI]
30. 노종성, "고지방식이 유도 비알콜성지방간 마우스 모델에서 六神麯의 脂肪肝 개선효과", 대한본초학회지, 29(2), pp.23~31 (2014), 대한본초학회
31. 장두현, "고지방식이 비만마우스 모델에서 降脂丸과 降脂丸+加味消滯丸의 비알콜성 지방간질환 개선효과 비교", 대한한의학 방제학회지, 22(1), pp.167~176 (2014), 대한한의학방제학회
32. Herbal medicine Compilation Committee of College of Oriental Medicine, "Herbal Medicine", pp.186~188 (2011), Jeongseonsa
33. Panahi Y, "Mitigation of systemic oxidative stress by curcuminoids in osteoarthritis : results of a randomized controlled trial", Journal of Dietary Supplements, 13(2), pp.209~229 (2016)
34. Panahi Y, "Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard : a randomized controlled trial", Journal of Dietary Supplements, 13(1), pp.93~105 (2016)
35. Panahi Y, "Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome : a randomized controlled trial and an updated meta-analysis", Clinical nutrition, 34(6), pp.1101~1109 (2015)
36. Panahi Y, "Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin : results of a randomised, double-blind, placebo-controlled trial", British Journal of Nutrition, 108(7), pp.1272~1281 (2012)
37. Panahi Y, "Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors : a randomized double-blind placebocontrolled trial", Phytotherapy Research, 28(10), pp.1461~1467 (2014)
38. Panahi Y, "A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications", Annals of Clinical Biochemistry:an international journal of biochemistry in medicine, 49(Pt6), pp.580~588 (2012)
39. Sahebkar A, "Are curcuminoids effective C-reactive protein-lowering agents in clinical practice?Evidence from a meta-analysis", Phytotherapy Research, 28(5), pp.633~642 (2014)
40. Chuengsamarn S, "Curcumin extract for prevention of type 2 diabetes", Diabetes Care, 35(11), pp.2121~2128 (2012)
41. Chuengsamarn S, "Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract : a randomized controlled trial", J Nutr Biochem, 25(2), pp.144~150 (2014)
42. Sahebkar A, "Low-density lipoprotein is a potential target for curcumin : novel mechanistic insights", Basic &Clinical Pharmacology &Toxicology, 114(6), pp.437~438 (2014)
43. Li HB, "Study on lipid-regulating function for the extracts and their prescriptions from Semen Cassiae and fructus crataegi", Journal of Chinese Medicinal Materials, 30(5), pp.573~578 (2007)
44. Niu C, "Decrease of blood lipids induced by Shan-Zha(fruit of Crataegus pinnatifida)is mainly related to an increase of PPARαin liver of mice fed high-fat diet", Hormone and Metabolic Research, 43(9), pp.625~655 (2011)
45. Zhang ZP, "Effect of a compound Danshen preparation in preventing long-term gastric lipid emulsion administration-induced nonalcoholic steatohepatitis in rats", Journal of Southern Medical University, 28(7), pp.1109~1122 (2008)
46. Kang DG, "Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system", Am J Chin Med, 30(1), pp.87~93 (2002)
47. Liu G, "Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism", Journal of Chinese Integrative Medicine, 3(6), pp.459~521 (2005)
48. 권영모, "시호가 acetaminophen으로 유도된 간손상 흰쥐에 미치는 영향", 대한본초학회지, 19(4), pp.91~104 (2004), 대한본초학회
49. Lee E, "Effects of Siho(Bupleuri Radix)extracts on serum lipid composition and antioxidant system in rat fed high fat diet", The Korean Journal of Oriental Medical Prescription, 11(1), pp.151~159 (2003)
50. Lindor KD, "Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis : results of a randomized trial", Hepatology, 39(3), pp.770~778 (2004)
51. Leuschner UF, "High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis : a doubleblind, randomized, placebo-controlled trial", Hepatology, 52(2), pp.472~479 (2010)
52. Petyaev IM, "Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine : A Preliminary Report", International Journal of Chronic Diseases, 2018, pp.1~7 (2018)
53. "Thiola"[URL]
54. Mulrow C, "Report on milk thistle : effects on liver disease and cirrhosis and clinical adverse effects", Evidence report, 2000, pp.21, 1~3
55. Lazo M, "Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes", Diabetes Care, 33(10), pp.2156~2219 (2010)
56. Marra F, "Adipokines in liver diseases", Hepatology, 50(3), pp.957~1026 (2009)

관련 논문AI추천